Helix Japan

Helix Japan is a healthcare and medical device company specializing in the development, manufacturing, and distribution of high-performance hydrogen gas inhalation systems. The company's flagship products, including the Hycellvator ET100 and PF72, utilize advanced water electrolysis technology to generate high-purity molecular hydrogen for health, beauty, and clinical applications. Helix Japan's devices are widely utilized in hospitals, clinics, and therapy centers across Japan and are actively involved in clinical research evaluating the therapeutic benefits of hydrogen inhalation for conditions such as advanced colorectal cancer, head and neck cancer, and post-cardiac arrest syndrome. By leveraging molecular hydrogen's properties as a selective antioxidant that reduces reactive oxygen species (ROS), the company aims to mitigate oxidative stress and inflammation to improve patient outcomes.